We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Multiplex Diagnostic Test Identifies Eighteen Common Respiratory Pathogens

By Biotechdaily staff writers
Posted on 25 Sep 2007
A multiplex-formatted diagnostic test can identify the most common viruses and bacteria that cause respiratory infections in a single reaction tube.

Eleven different respiratory RNA viruses, two DNA viruses, and five pneumonia bacteria can be identified from samples including nasopharyngeal aspirates, nasopharyngeal swabs, and bronchoalveolar lavage.

Traditional tests, such as viral culture and Ag-Ab test, are laborious, time-consuming, and relatively expensive. More...
By enabling healthcare personnel to test for 18 different pathogens for a cost comparable to testing a single pathogen, the Seeplex 18-plex respiratory test changes the system of a ‘single pathogen, single test' testing regime and avoids the high false-positive/negative results associated with conventional multiplexing. The Seeplex 18-plex respiratory test performs multiplexing without cross-reactivity and achieves rapid test results at a minimal cost per test.

The microorganisms detected by the Seeplex test are influenza A virus; influenza B virus; human respiratory syncytial virus A; human respiratory syncytial virus B; human parainfluenzae virus 1; human parainfluenzae virus 2; human parainfluenzae virus 3; human Coronavirus 229E/Nl63; human Coronavirus OC43/HKU1; human Rhinovirus; human Enterovirus; human adenovirus; human Bocavirus; Legionella pneumophila; Streptococcus pneumoniae; Chlamydophila pneumoniae; Haemophilus influenzae; and Mycoplasma pneumoniae.

Developed by Seegene (Rockville, MD, USA), the Seeplex test is based on multiplexing polymerase chain reaction (PCR) technology. It enables healthcare personnel to rapidly determine whether a patient's respiratory ailment is caused by a virus or bacteria, and subsequently prescribe the best course of treatment whether an antibiotic, antiviral, or bed rest.

"Our new 18-plex Respiratory Test is what the clinical healthcare industry has been asking for--the ability to routinely test for a wide spectrum of respiratory pathogens in a single test, at the price of a single pathogen test,” stated Jong-Yoon Chun, founder and CEO, Seegene. "Like our other commercially available tests, notably the recently introduced 18-plex test for human Papillomaviruses, our new respiratory test is simply performed with one multiplex PCR in a single tube and capillary electrophoresis for automated detection of pathogens. These tests use Seegene's DPO [Dual Priming Oligo] primer system, ensuring test reproducibility, specificity, and sensitivity.


Related Links:
Seegene

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: The GenoPredict assay from Predicta Biosciences is available to Tempus Life Sciences partners to support exploratory research and clinical development programs (photo courtesy of Shutterstock)

Partnership Expands Ultrasensitive WGS Assay for for Hematologic Malignancies and MRD Monitoring

Tempus AI and Predicta Biosciences announced the commercial expansion of a co-branded whole‑genome sequencing assay GenoPredicta, which is intended for comprehensive genomic characterization of hematologic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.